Podcast: Scaling up science - how to grow your life sciences venture
Browse this blog post
Related news and insights
Publications: 04 April 2024
Integrating Sustainability: Luxembourg's Legal Advancements with the CSRD
Blog Post: 03 April 2024
European Commission opens unprecedented abuse of dominance probe in animal medicines sector
Blog Post: 28 March 2024
News: 27 March 2024
Allen & Overy advises on the sale of majority stake in GasNet
In our latest life sciences podcast, Tine Carmeliet and Juno Hautekiet interview two CEOs who have chosen very different routes for growing their biotech ventures.
Tim Knotnerus of Agomab Therapeutics, one of the most promising therapeutics companies in Europe and one of 2022’s “Fierce 15” honorees, shares how to create optionality and how he recently secured a USD 114 million Series B financing. Claudine van der Sande, former founder and CEO of Xinvento, a biotech aiming to improve the lives of those with Congenital Hyperinsulinism, reveals why she instead decided to sell her company and how she managed to do this with the company still in its preclinical development phase.
Join us on this podcast as we explore their motives, priorities and advice for future biotechs.
